These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27733576)

  • 61. OCTN2-mediated transport of carnitine in isolated Sertoli cells.
    Kobayashi D; Goto A; Maeda T; Nezu J; Tsuji A; Tamai I
    Reproduction; 2005 Jun; 129(6):729-36. PubMed ID: 15923388
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis, transport and mechanism of a type I prodrug: L-carnitine ester of prednisolone.
    Mo JX; Shi SJ; Zhang Q; Gong T; Sun X; Zhang ZR
    Mol Pharm; 2011 Oct; 8(5):1629-40. PubMed ID: 21854030
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier.
    Miecz D; Januszewicz E; Czeredys M; Hinton BT; Berezowski V; Cecchelli R; Nałecz KA
    J Neurochem; 2008 Jan; 104(1):113-23. PubMed ID: 17995936
    [TBL] [Abstract][Full Text] [Related]  

  • 64. beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.
    Ganapathy ME; Huang W; Rajan DP; Carter AL; Sugawara M; Iseki K; Leibach FH; Ganapathy V
    J Biol Chem; 2000 Jan; 275(3):1699-707. PubMed ID: 10636865
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation.
    Lehtonen A; Matikainen S; Miettinen M; Julkunen I
    J Leukoc Biol; 2002 Mar; 71(3):511-9. PubMed ID: 11867689
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Carnitine transport: pathophysiology and metabolism of known molecular defects.
    Tein I
    J Inherit Metab Dis; 2003; 26(2-3):147-69. PubMed ID: 12889657
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Maternal Plasma l-Carnitine Reduction During Pregnancy Is Mainly Attributed to OCTN2-Mediated Placental Uptake and Does Not Result in Maternal Hepatic Fatty Acid
    Bai M; Zeng Q; Chen Y; Chen M; Li P; Ma Z; Sun D; Zhou H; Zheng C; Zeng S; Jiang H
    Drug Metab Dispos; 2019 Jun; 47(6):582-591. PubMed ID: 30918014
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional analysis of OCTN2 and ATB0,+ in normal human airway epithelial cells.
    Rotoli BM; Visigalli R; Barilli A; Ferrari F; Bianchi MG; Di Lascia M; Riccardi B; Puccini P; Dall'Asta V
    PLoS One; 2020; 15(2):e0228568. PubMed ID: 32027707
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of the gene encoding carnitine transporter (OCTN2/SLC22A5) expression in human breast cancer and its association with clinicopathological characteristics.
    Dinarvand N; Karimi F; Azizi R; Rastaghi S; Sheikhi A; Pourfarzam M
    Mol Biol Rep; 2023 Mar; 50(3):2061-2066. PubMed ID: 36539562
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Advances in the study of regulation of novel organic cation transporter-2].
    Wang FR; Guo RC
    Yao Xue Xue Bao; 2009 Oct; 44(10):1061-5. PubMed ID: 20055125
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
    Wang C; Uray IP; Mazumdar A; Mayer JA; Brown PH
    Breast Cancer Res Treat; 2012 Jul; 134(1):101-15. PubMed ID: 22212555
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy.
    Makhseed N; Vallance HD; Potter M; Waters PJ; Wong LT; Lillquist Y; Pasquali M; Amat di San Filippo C; Longo N
    J Inherit Metab Dis; 2004; 27(6):778-80. PubMed ID: 15617188
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cotransporting Ion is a Trigger for Cellular Endocytosis of Transporter-Targeting Nanoparticles: A Case Study of High-Efficiency SLC22A5 (OCTN2)-Mediated Carnitine-Conjugated Nanoparticles for Oral Delivery of Therapeutic Drugs.
    Kou L; Yao Q; Sun M; Wu C; Wang J; Luo Q; Wang G; Du Y; Fu Q; Wang J; He Z; Ganapathy V; Sun J
    Adv Healthc Mater; 2017 Sep; 6(17):. PubMed ID: 28661032
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
    Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
    J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Organic cation/carnitine transporter, OCTN2, is differentially expressed in the adult rat epididymis.
    Rodríguez CM; Labus JC; Hinton BT
    Biol Reprod; 2002 Jul; 67(1):314-9. PubMed ID: 12080034
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PDZ adaptor protein PDZK2 stimulates transport activity of organic cation/carnitine transporter OCTN2 by modulating cell surface expression.
    Watanabe C; Kato Y; Sugiura T; Kubo Y; Wakayama T; Iseki S; Tsuji A
    Drug Metab Dispos; 2006 Nov; 34(11):1927-34. PubMed ID: 16896066
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5).
    Grube M; Meyer zu Schwabedissen HE; Präger D; Haney J; Möritz KU; Meissner K; Rosskopf D; Eckel L; Böhm M; Jedlitschky G; Kroemer HK
    Circulation; 2006 Feb; 113(8):1114-22. PubMed ID: 16490820
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption.
    Nakamura T; Nakanishi T; Haruta T; Shirasaka Y; Keogh JP; Tamai I
    Mol Pharm; 2010 Feb; 7(1):187-95. PubMed ID: 20020740
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta.
    Grube M; Meyer Zu Schwabedissen H; Draber K; Präger D; Möritz KU; Linnemann K; Fusch C; Jedlitschky G; Kroemer HK
    Drug Metab Dispos; 2005 Jan; 33(1):31-7. PubMed ID: 15486076
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mechanism of the inhibitory effect of zwitterionic drugs (levofloxacin and grepafloxacin) on carnitine transporter (OCTN2) in Caco-2 cells.
    Hirano T; Yasuda S; Osaka Y; Kobayashi M; Itagaki S; Iseki K
    Biochim Biophys Acta; 2006 Nov; 1758(11):1743-50. PubMed ID: 16928358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.